Spexis to host business update conference call on October 9, 2023

ALLSCHWIL, Switzerland, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Spexis AG (SIX: SPEX), a clinical-stage biopharmaceutical company focused on macrocycle therapeutics for rare diseases and oncology, announced today that it will host a business update conference call on October 9, 2023, at 8.30am EDT.

Jeffrey D. Wager, M.D. (CEO & Chairman) will provide strategic business and financial updates. To access the conference call please use the following details:

France: [phone]
Germany: [phone]
Italy: [phone]
Switzerland [phone]
United Kingdom [phone]
United States [phone]
International Toll Free [phone]

Event Title: Spexis AG – Business Update Conference Call

The conference call will also be available via webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=6s6eCE7g

After the call, a replay of the webcast will be available via the above link.

About Spexis

Spexis (SIX: SPEX) is a clinical-stage biopharmaceutical company based in Allschwil, Switzerland, focused on macrocycle therapeutics for rare diseases and oncology. For further information please visit: www.spexisbio.com.

For further information please contact:

For Investors: 

Hernan Levett
Chief Financial Officer
Spexis AG.
[phone]
[e-mail]

Or

Stephen Jasper
Managing Director
Gilmartin Group
[e-mail]

For Media: 

Dr. Stephan Feldhaus
Feldhaus & Partner
[phone]
[e-mail]

Source: Spexis AG

2023 GlobeNewswire, Inc., source Press Releases